Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Dec 15;2(6204):1571–1572. doi: 10.1136/bmj.2.6204.1571

Multiple sclerosis: what can and cannot be done.

E J Field, G Joyce
PMCID: PMC1597463  PMID: 534872

Full text

PDF
1571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bisaccia G., Caputo D., Zibetti A. E-UFA test in multiple sclerosis. Boll Ist Sieroter Milan. 1978 Jan 31;56(6):583–588. [PubMed] [Google Scholar]
  2. Field E. J., Joyce G. Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur Neurol. 1978;17(2):67–76. doi: 10.1159/000114926. [DOI] [PubMed] [Google Scholar]
  3. Field E. J., Joyce G., Smith B. M. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. J Neurol. 1977 Jan 13;214(2):113–127. doi: 10.1007/BF02430349. [DOI] [PubMed] [Google Scholar]
  4. Field E. J. Polyunsaturated fatty acids in multiple sclerosis. Br Med J. 1979 Apr 14;1(6169):1016–1017. doi: 10.1136/bmj.1.6169.1016-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Seaman G. V., Swank R. L., Tamblyn C. H., Zukoski C. F., 4th Simplified red-cell electrophoretic mobility test for multiple sclerosis. Lancet. 1979 May 26;1(8126):1138–1139. doi: 10.1016/s0140-6736(79)91813-0. [DOI] [PubMed] [Google Scholar]
  6. Thompson R. H. A biochemical approach to the problem of multiple sclerosis. Proc R Soc Med. 1966 Mar;59(3):269–276. doi: 10.1177/003591576605900332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Thompson R. H. Fatty acid metabolism in multiple sclerosis. Biochem Soc Symp. 1972;(35):103–111. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES